Contador's Dominant First Giro: The 2008 Edition and Riccò's Fall from Grace
The 2008 Giro d'Italia will be remembered as the year Alberto Contador announced himself as a Grand Tour champion with an authoritative and dominant victory that silenced any doubters about the young Spanish climber's credentials. Contador, riding for Liberty Seguros, controlled the race with a maturity beyond his years, taking the pink jersey on stage 15 at the Passo Fedaia and never surrendering it through to Milan. His final margin of 1 minute and 57 seconds over runner-up Riccardo Riccò was commanding, though the aftermath of the race would cast a long shadow over the results.
Remarkably, Contador won the Giro without claiming a single stage victory, a testament to his consistency and efficiency in the mountains. His performances were relentlessly strong, with controlled aggression on the decisive climbs and careful management in the time trials. The Spanish prodigy gained ground incrementally, grinding down his rivals through superior fitness and tactical awareness. By the final stages, the outcome was never in doubt, and Contador was able to cruise to victory in Milan, securing his first Grand Tour title at just 25 years old.
The race took a darker turn when Riccardo Riccò, Contador's closest challenger in second place, tested positive for CERA (Continuous Erythropoiesis Receptor Activator), a third-generation form of EPO, from samples taken during the Tour de France in July 2008. Riccò's subsequent ban and confession implicated the doping culture that had plagued professional cycling throughout the 2000s. The bright young Italian climber, who had impressed with his aggression and mountain prowess, had achieved his strong second-place finish through chemical enhancement rather than pure talent.
Riccò's downfall was particularly symbolic of the era. At just 24 years old, he had been billed as the future of Italian cycling, a bold climber with genuine Grand Tour potential. His performances at the 2008 Giro demonstrated his climbing ability, taking two stage victories and the white jersey for best young rider. Yet his CERA use exposed the endemic doping that continued to plague the sport despite increased testing and biological passport programs. Years later, Riccò would make startling claims about the impossibility of winning Grand Tours without doping, allegations that cast even Contador's victory under intense scrutiny when the Spaniard himself would later face his own doping-related controversy.
The 2008 Giro d'Italia also featured Marzio Bruseghin rounding out the podium in third place, but the narrative of the race was dominated by the contrast between Contador's brilliant racing intelligence and Riccò's tainted triumph. The Italian climber's ejection from the race results exemplified cycling's ongoing struggle with its doping past and the difficulty of distinguishing genuine achievement from pharmaceutical-enhanced performances during this dark period of the sport.
Contador's Giro success would lead to a historic season, as he would go on to win the 2008 Tour de France with Astana, becoming the third Spanish rider to win the Tour. His 2008 campaign, built on the foundation of this dominant Giro performance, cemented him as the dominant stage racer of the era. The Spanish champion's ability to win major Tours without stage victories—purely through consistency and superior climbing—represented an evolution in Grand Tour tactics and demonstrated the effectiveness of conservative, calculated racing strategies.
The aftermath of the 2008 Giro d'Italia symbolized the complexity of cycling history during the EPO era. Contador's victory would later be overshadowed by his own 2010 clenbuterol case, leaving questions about the legitimacy of performances during this period. Yet at the time, his dominance and control of the 2008 race was undeniable, showcasing the tactical brilliance and climbing prowess that would define his career as one of the greatest stage racers of the 21st century.